MiMedx Group, Inc. (MDXG)

NCM – Real vaqt narxi. Valyuta: USD

3.54

-0.02 (-0.56%)

Yopilishda: May 12, 2026, 4:00 PM EDT

3.54

0.00 (0.00%)

Bozordan keyin: May 12, 2026, 6:55 PM EDT

08.05.2026

MIMEDX Announces Launch of G4Derm® Plus

Flowable Biomimetic Matrix Adds Self-Assembling Peptide Technology to Company's Portfolio G4Derm Plus Added to Premier and Vizient GPO Agreements MARIETTA, Ga., May 08, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the commercial launch of G4Derm Plus, with initial sales of the product already delivered to customers nationwide.

07.05.2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG

NEW YORK, May 7, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of MiMedx Group, Inc. ("MiMedx" or the "Company") (NASDAQ: MDXG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

30.04.2026

MiMedx Group, Inc. (MDXG) Q1 2026 Earnings Call Transcript

29.04.2026

MiMedx (MDXG) Reports Q1 Loss, Tops Revenue Estimates

MiMedx (MDXG) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to earnings of $0.06 per share a year ago.

29.04.2026

MIMEDX Announces First Quarter 2026 Operating & Financial Results

Reports First Quarter Net Sales of $59 Million Revises 2026 Net Sales and Adjusted EBITDA Expectations Management to Host Conference Call Today, April 29, 2026, at 4:30 PM ET MARIETTA, Ga., April 29, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the first quarter 2026.

22.04.2026

Earnings Preview: MiMedx (MDXG) Q1 Earnings Expected to Decline

MiMedx (MDXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

22.04.2026

MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29

MARIETTA, Ga., April 22, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the first quarter ended March 31, 2026 after the market close on Wednesday, April 29, 2026. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.

Videolar

No Data

There is no data to display

Press-relizlar

08.05.2026

MIMEDX Announces Launch of G4Derm® Plus

07.05.2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG

29.04.2026

MIMEDX Announces First Quarter 2026 Operating & Financial Results

16.04.2026

MIMEDX Announces Restructuring and Cost Reduction Initiative

MARIETTA, Ga., April 16, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced a series of cost reduction initiatives intended to prioritize growth opportunities, streamline operations and significantly reduce operating expenses.

MiMedx Group, Inc. (MDXG)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

MiMedx Group, Inc. (MDXG)

MIMEDX Announces Launch of G4Derm® Plus

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG

MiMedx Group, Inc. (MDXG) Q1 2026 Earnings Call Transcript

MiMedx (MDXG) Reports Q1 Loss, Tops Revenue Estimates

MIMEDX Announces First Quarter 2026 Operating & Financial Results

Earnings Preview: MiMedx (MDXG) Q1 Earnings Expected to Decline

MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29

Videolar

No Data

Press-relizlar

MIMEDX Announces Launch of G4Derm® Plus

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG

MIMEDX Announces First Quarter 2026 Operating & Financial Results

MIMEDX Announces Restructuring and Cost Reduction Initiative

MIMEDX Announces Launch of G4Derm® Plus

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG

MiMedx Group, Inc. (MDXG) Q1 2026 Earnings Call Transcript

MiMedx (MDXG) Reports Q1 Loss, Tops Revenue Estimates

MIMEDX Announces First Quarter 2026 Operating & Financial Results

Earnings Preview: MiMedx (MDXG) Q1 Earnings Expected to Decline

MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29

Videolar

No Data

Press-relizlar

MIMEDX Announces Launch of G4Derm® Plus

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG

MIMEDX Announces First Quarter 2026 Operating & Financial Results

MIMEDX Announces Restructuring and Cost Reduction Initiative

Search stocks

MiMedx Group, Inc. (MDXG)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

MiMedx Group, Inc. (MDXG)

MIMEDX Announces Launch of G4Derm® Plus

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG

MiMedx Group, Inc. (MDXG) Q1 2026 Earnings Call Transcript

MiMedx (MDXG) Reports Q1 Loss, Tops Revenue Estimates

MIMEDX Announces First Quarter 2026 Operating & Financial Results

Earnings Preview: MiMedx (MDXG) Q1 Earnings Expected to Decline

MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29

Videolar

No Data

Press-relizlar

MIMEDX Announces Launch of G4Derm® Plus

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG

MIMEDX Announces First Quarter 2026 Operating & Financial Results

MIMEDX Announces Restructuring and Cost Reduction Initiative

MIMEDX Announces Launch of G4Derm® Plus

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG

MiMedx Group, Inc. (MDXG) Q1 2026 Earnings Call Transcript

MiMedx (MDXG) Reports Q1 Loss, Tops Revenue Estimates

MIMEDX Announces First Quarter 2026 Operating & Financial Results

Earnings Preview: MiMedx (MDXG) Q1 Earnings Expected to Decline

MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29

Videolar

No Data

Press-relizlar

MIMEDX Announces Launch of G4Derm® Plus

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG

MIMEDX Announces First Quarter 2026 Operating & Financial Results

MIMEDX Announces Restructuring and Cost Reduction Initiative